top of page

Clarithromycin

Grade

Sensitive Infections

Therapeutics

Evidence

  1. Fong, I.W., 2000. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. J Infect Dis 181 Suppl 3, S514-518. https://doi.org/10.1086/315607

  2. Fong, I.W., Chiu, B., Viira, E., Jang, D., Mahony, J.B., 2002. Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother 46, 2321–2326. https://doi.org/10.1128/AAC.46.8.2321-2326.2002

  3. Giamarellos-Bourboulis, E.J., Antonopoulou, A., Raftogiannis, M., Koutoukas, P., Tsaganos, T., Tziortzioti, V., Panagou, C., Adamis, T., Giamarellou, H., 2006a. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa. BMC Infect Dis 6, 31. https://doi.org/10.1186/1471-2334-6-31

  4. Giamarellos-Bourboulis, E.J., Tziortzioti, V., Koutoukas, P., Baziaka, F., Raftogiannis, M., Antonopoulou, A., Adamis, T., Sabracos, L., Giamarellou, H., 2006b. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae. J Antimicrob Chemother 57, 937–944. https://doi.org/10.1093/jac/dkl084

  5. Gross, R.H., Holland, G.N., Elias, S.J., Tuz, R., 1995. Corneal pharmacokinetics of topical clarithromycin. Invest Ophthalmol Vis Sci 36, 965–968.

  6. Helm, C.J., Holland, G.N., Lin, R., Berlin, O.G., Bruckner, D.A., 1993. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. Am J Ophthalmol 116, 700–707. https://doi.org/10.1016/s0002-9394(14)73469-5

  7. Hu, F.R., Wang, I.J., 1998. Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model. Curr Eye Res 17, 478–482. https://doi.org/10.1076/ceyr.17.5.478.5195

  8. Hume, E.B., Moreau, J.M., Conerly, L.L., Cannon, B.M., Dajcs, J.J., Hill, J.M., O’Callaghan, R.J., 1999. Clarithromycin for experimental Staphylococcus aureus keratitis. Curr Eye Res 18, 358–362. https://doi.org/10.1076/ceyr.18.5.358.5350

  9. Kuehne, J.J., Yu, A.L.T., Holland, G.N., Ramaswamy, A., Taban, R., Mondino, B.J., Yu, F., Rayner, S.A., Giese, M.J., 2004. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. Am J Ophthalmol 138, 547–553. https://doi.org/10.1016/j.ajo.2004.04.071

  10. Liapakis, I.E., Light, R.W., Pitiakoudis, M.S., Karayiannakis, A.J., Giamarellos-Bourboulis, E.J., Ismailos, G., Anagnostoulis, S., Simopoulos, C.E., Bouros, D.E., 2005. Penetration of clarithromycin in experimental pleural empyema model fluid. Respiration 72, 296–300. https://doi.org/10.1159/000085371

  11. Shirtliff, M.E., Mader, J.T., Calhoun, J., 1999. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. Clin Orthop Relat Res 229–236. https://doi.org/10.1097/00003086-199902000-00026

  12. Szałek, E., Karbownik, A., Połom, W., Matuszewski, M., Sobańska, K., Urjasz, H., Grabowski, T., Wolc, A., Grześkowiak, E., 2012. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? Pharmacol Rep 64, 1554–1559. https://doi.org/10.1016/s1734-1140(12)70953-2

  13. Tsovolou, E.-C., Tzepi, I.-M., Spyridaki, A., Tsaganos, T., Karagianni, V., Menenakos, E., Liakou, P., Sabracos, L., Zografos, G., Giamarellos-Bourboulis, E.J., 2014. Effect of clarithromycin in experimental empyema by multidrug-resistant Pseudomonas aeruginosa. APMIS 122, 68–75. https://doi.org/10.1111/apm.12094

  14. Unal, M., Peyman, G.A., Liang, C., Hegazy, H., Molinari, L.C., Chen, J., Brun, S., Tarcha, P.J., 1999. Ocular toxicity of intravitreal clarithromycin. Retina 19, 442–446. https://doi.org/10.1097/00006982-199909000-00013

  15. Wang, J., Li, X., Xiong, L., Sun, N., 2008. [Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by Staphylococcus aureus]. Yan Ke Xue Bao 24, 18–22.

  16. Weiss, S., Altboum, Z., Glinert, I., Schlomovitz, J., Sittner, A., Bar-David, E., Kobiler, D., Levy, H., 2015. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits. Antimicrob Agents Chemother 59, 7497–7503. https://doi.org/10.1128/AAC.01376-15

  17. Zhang, J., Wang, L., Zhou, J., Zhang, L., Xia, H., Zhou, T., Zhang, H., 2014. Ocular penetration and pharmacokinetics of topical clarithromycin eye drops to rabbits. J Ocul Pharmacol Ther 30, 42–48. https://doi.org/10.1089/jop.2013.0042

Monograph Details

bottom of page